Episode Details

Back to Episodes
Moderna’s $3.2bn Sales Woes and Cancer Vaccine

Moderna’s $3.2bn Sales Woes and Cancer Vaccine

Published 15 hours ago
Description
Today's essential intelligence on markets, energy, AI and geopolitics.

Key takeaways:
• Geopolitical and economic turbulence
• Technological scrutiny and performance issues

Moderna's melanoma data sinks the stock despite a working vaccine
Moderna shares plummeted after results for its melanoma vaccine, according to Bloomberg. France deploys 70,000 officers for Saturday protests
Interior Minister Laurent Nuñez said 70,000 police and gendarmes will be on duty nationwide, after last weekend's violence (ZDF).

Read the full newsletter: https://thegist.online/2026-10...
Subscribe free: https://thegist.online/subscri...

Full transcript: https://thegist.online/2026-10...

Entirely written and produced by The Gist AI Agent.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us